BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 15268713)

  • 1. Hidradenoma papilliferum with mixed histopathologic features of syringocystadenoma papilliferum and anogenital mammary-like glands.
    Nishie W; Sawamura D; Mayuzumi M; Takahashi S; Shimizu H
    J Cutan Pathol; 2004 Sep; 31(8):561-4. PubMed ID: 15268713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hidradenoma papilliferum with mixed histopathologic features of syringocystadenoma papilliferum and anogenital mammary-like glands: report of a case and review of the literature.
    Parks A; Branch KD; Metcalf J; Underwood P; Young J
    Am J Dermatopathol; 2012 Feb; 34(1):104-9. PubMed ID: 22262361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tubular apocrine adenoma in association with syringocystadenoma papilliferum.
    Aktepe F; Demir Y; Dilek FH
    Dermatol Online J; 2003 Feb; 9(1):7. PubMed ID: 12639465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hidradenoma papilliferum of the vulva in association with an anogenital mammary-like gland.
    Kurashige Y; Kishida K; Kurashige K; Minemura T; Nagatani T
    J Dermatol; 2014 May; 41(5):411-3. PubMed ID: 24617304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hidradenoma papilliferum of the upper eyelid arising from the apocrine gland of Moll.
    Netland PA; Townsend DJ; Albert DM; Jakobiec FA
    Ophthalmology; 1990 Dec; 97(12):1593-8. PubMed ID: 1965020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syringocystadenoma papilliferum associated with apocrine poroma.
    Suzuki T; Ikeda H; Hamasaki Y; Hatamochi A; Yamazaki S
    J Dermatol; 2006 Apr; 33(4):249-51. PubMed ID: 16674787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anatomoclinical and immunohistochemical study of hidradenoma papilliferum, a tumor deriving from anogenital mammary-like glands].
    Blind A; Weingertner N; Cribier B
    Ann Dermatol Venereol; 2019 Sep; 146(8-9):528-536. PubMed ID: 31285043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical apocrine proliferation involving anogenital mammary-like glands of the perianal region.
    Charfi S; Sevestre H; Dumont F; Regimbeau JM; Chatelain D
    J Cutan Pathol; 2009 Oct; 36 Suppl 1():52-5. PubMed ID: 19775395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syringocystadenoma papilliferum: a rare breast tumor in a young boy.
    Vaos G; Pierrakou P
    Pediatr Dev Pathol; 2006; 9(5):381-3. PubMed ID: 16953682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital papillated apocrine cystadenoma: a mixed form of hidrocystoma, hidradenoma papilliferum, and syringocystadenoma papilliferum.
    Schewach-Millet M; Trau H
    J Am Acad Dermatol; 1984 Aug; 11(2 Pt 2):374-6. PubMed ID: 6090513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of sebaceoma with extensive apocrine differentiation.
    Tanahashi J; Kashima K; Daa T; Kondoh Y; Yada N; Kuratomi E; Yokoyama S
    Am J Dermatopathol; 2008 Aug; 30(4):408-11. PubMed ID: 18645320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squamous cell apocrine hidradenoma.
    Angulo J; Jaqueti G; Kutzner H; Requena L
    J Cutan Pathol; 2007 Oct; 34(10):801-3. PubMed ID: 17880588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moll gland neoplasms of the eyelid: a clinical and pathological spectrum in 5 cases.
    Barker-Griffith AE; Streeten BW; Charles NC
    Arch Ophthalmol; 2006 Nov; 124(11):1645-9. PubMed ID: 17102015
    [No Abstract]   [Full Text] [Related]  

  • 14. Mixed tubulopapillary hidradenoma and syringocystadenoma papilliferum occurring as a verrucous tumor.
    Hsu PJ; Liu CH; Huang CJ
    J Cutan Pathol; 2003 Mar; 30(3):206-10. PubMed ID: 12641782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facial apocrine fibroadenoma in man: a rare finding.
    Liu HN; Chang YT; Chen CC; Yang AH
    Am J Dermatopathol; 2007 Jun; 29(3):274-8. PubMed ID: 17519626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-anogenital (ectopic) hidradenoma papilliferum with sebaceous differentiation: a case report and review of reported cases.
    Minami S; Sadanobu N; Ito T; Natsuaki M; Yamanishi K
    J Dermatol; 2006 Apr; 33(4):256-9. PubMed ID: 16674789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous leiomyosarcoma, trichoblastoma, and syringocystadenoma papilliferum arising from nevus sebaceus.
    Premalata CS; Kumar RV; Malathi M; Shenoy AM; Nanjundappa N
    Int J Dermatol; 2007 Mar; 46(3):306-8. PubMed ID: 17343592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical fibroxanthoma arising in an area of syringocystadenoma papilliferum associated with nevus sebaceus: positivity of the atypical fibroxanthoma component for CD31.
    Tronnier M; Vogelbruch M
    J Cutan Pathol; 2007 Dec; 34 Suppl 1():58-63. PubMed ID: 17997741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syringocystadenoma papilliferum with sebaceous differentiation in an intradermal tubular apocrine component. Report of a case.
    Vazmitel M; Michal M; Mukensnabl P; Kazakov DV
    Am J Dermatopathol; 2008 Feb; 30(1):51-3. PubMed ID: 18212545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vulvar hidradenoma papilliferum (HP) is located on the sites of mammary-like anogenital glands (MLAGs): Analysis of the photographs of 52 tumors.
    El-Khoury J; Renald MH; Plantier F; Avril MF; Moyal-Barracco M
    J Am Acad Dermatol; 2016 Aug; 75(2):380-4. PubMed ID: 26944596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.